Ivermectin has been shown to be effective in a single oral dose for the treatment of patients with common crusted scabies. However, worrisome information about the safety of ivermectin in patients treated for scabies has recently been reported.1 An increase in the number of deaths within the first 6 months following treatment in elderly patients has been reported. In the dermatologic community, a polemic has been developing regarding the common use of this drug for treatment of patients with scabies, especially elderly patients.2-6 In 1993, Marty et al7 used this drug to treat a community epidemic of scabies in a nursing home population. We have retrospectively studied the long-term outcomes of these patients.
del Giudice P, Marty P, Gari-Toussaint M, Le Fichoux Y. Ivermectin in Elderly Patients. Arch Dermatol. 1999;135(3):351–352. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-135-3-dlt0399
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: